Business Fit is well supported by the current intake. The business case is detailed enough to support a serious approval discussion. Residual risk remains because approval caveat risk: the intake already notes approval conditions that still need explicit closure and ownership..
Positive signals
- The business case is detailed enough to support a serious approval discussion.
- The intended business outcome is explicit enough to guide decision-making.
Risks to close
- Approval caveat risk: the intake already notes approval conditions that still need explicit closure and ownership.
- Unclear measurement risk: success metrics are listed, but the intake does not record the current baseline or metric owner yet.
Recommended actions
- Turn the approval notes into named approval conditions with owners and close dates.
- Add a baseline and reporting owner for each success metric so ROI can be validated later.
Scope Clarity is well supported by the current intake. The scope summary provides a usable narrative baseline for review. Residual risk remains because scope expansion risk: optional asks are already visible, so approval should explicitly confirm they are not bundled into the baseline..
Positive signals
- The scope summary provides a usable narrative baseline for review.
- Requirements are captured at a level reviewers can challenge and refine.
Risks to close
- Scope expansion risk: optional asks are already visible, so approval should explicitly confirm they are not bundled into the baseline.
- Completion-definition risk: the intake lists requirements, but it still does not define how reviewers will decide the scope is complete enough to approve.
Recommended actions
- Move optional requests into a clearly secondary list and confirm they are not implied in the approved baseline.
- Add approval criteria or acceptance language that explains what makes the baseline ready to approve.
Resource Readiness is well supported by the current intake. A sponsor is named, which gives the intake a clear escalation point. Residual risk remains because stakeholder availability risk: the intake lists stakeholders, but it does not yet confirm review cadence or response expectations from them..
Positive signals
- A sponsor is named, which gives the intake a clear escalation point.
- Stakeholder coverage suggests the intake is not being shaped in a single-function silo.
Risks to close
- Stakeholder availability risk: the intake lists stakeholders, but it does not yet confirm review cadence or response expectations from them.
- Capacity certainty risk: named owners exist, but the intake does not yet prove their allocation is protected or backed up.
Recommended actions
- Confirm stakeholder review cadence, decision windows, and escalation paths before kickoff planning starts.
- Validate actual allocation levels, backup coverage, and start timing for the named owners.
Timeline Confidence is well supported by the current intake. The date window looks reasonably sized for the current scope baseline. Residual risk remains because contingency risk: the intake sets target dates, but it does not yet show the buffer or recovery approach if a key milestone slips..
Positive signals
- The date window looks reasonably sized for the current scope baseline.
- Timeline notes provide enough sequencing or assumption context to support review.
Risks to close
- Contingency risk: the intake sets target dates, but it does not yet show the buffer or recovery approach if a key milestone slips.
Recommended actions
- Record the contingency approach for likely schedule slips or approval delays.
ROI Confidence is well supported by the current intake. The business rationale is detailed enough to support a value discussion. Residual risk remains because unclear measurement risk: success metrics are listed, but no baseline, review date, or reporting owner is captured yet..
Positive signals
- The business rationale is detailed enough to support a value discussion.
- Desired outcomes are specific enough to support benefit validation later.
Risks to close
- Unclear measurement risk: success metrics are listed, but no baseline, review date, or reporting owner is captured yet.
- Approval caveat risk: existing approval notes suggest conditions that may affect value realization if they are not closed before launch.
Recommended actions
- Add metric baselines, validation timing, and reporting ownership so ROI can be checked after launch.
- Review approval notes for any value-related caveats and convert them into explicit pre-approval conditions.